a total of 164 patients with non-hodgkin 's lymphoma ( nhl ) were randomized to receive cycles of treatment every 3 weeks with either ctp , ie , cyclophosphamide ( 400 mg/m2/day orally x 5 ) , teniposide ( vm-26 ) ( 100 mg/m2 iv x 1 ) , and prednisolone ( 60 mg/m2/day orally x 5 ) , or cop , ie , vincristine ( 1.4 mg/m2 iv x 1 ; maximum , 2 mg ) with the same cyclophosphamide and prednisolone doses listed above .
C0024305
non-hodgkin 's lymphoma
C0042679
vincristine